Long-time chief IP Counsel BJ Watrous quietly left the position at the end of last year to be replaced by former lead patent counsel
The world’s largest life sciences company demonstrates that it is still a major presence in the M&A landscape, despite its stated focus on organic growth.
An entity with sub-licensing rights is litigating with the re-vamped PIPCO’s patents in China, and some early validity results are encouraging
In an exclusive sit-down with IAM at the automaker’s headquarters, Yosuke Iida says that its latest royalty-free licence scheme can help transform the company’s business – and the environment
In an interview with IAM Rembrandts in the Attic author Kevin Rivette made the case for applicants spending a lot more on the prosecution process. We asked the market whether it agreed.
The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically
Ongoing royalty negotiations are revealed after US network operator reportedly notifies government. Why the conflict, which follows a 2016 dispute with T-Mobile, may alarm Nokia and Ericsson
Section 101 hearings end with Senator Tillis admitting that work needs to be done on key parts of the proposal; says to expect draft legislation after 4th July break
Move designed to influence debate in Europe and comes on same day as implementers publish their own guidelines.
In Return Mail SCOTUS rules that government cannot bring post issuance patent challenges; lawyers for University of Minnesota claim that decision supports their case currently before the CAFC
Transfer of microfluidics tech comes as San Diego-based Illumina faces a fierce IP fight with an upstart Chinese rival
Osaka-based firm seeks to fend off Toughbook rival with design rights, a field of IP that Japanese policymakers are seeking to boost with legislative IP reforms currently under consideration
Josh Malone’s Bunch O Balloons success has made him a leading figure in the invention community and positioned him to challenge some of the patent narratives on Capitol Hill
Assignments involving Korean tech giant and US software business demonstrate that it’s more than just NPEs that are interested in NPE assets
Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings